Trials / Unknown
UnknownNCT04396158
Effect of Radioiodine Therapy on Ovarian Reserve in Female Patients With Differentiated Thyroid Cancer
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 38 (estimated)
- Sponsor
- Assiut University · Academic / Other
- Sex
- Female
- Age
- 15 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
Thyroid carcinoma is the most common endocrine malignancy. Surgery is the standard therapeutic approach for patients with differentiated thyroid carcinoma (DTC), followed by radioiodine (RAI) therapy if indicated. For women with DTC, the effects of RAI therapy on gonadal and reproductive function are an important consideration. This study aimed to evaluate the effects of RAI therapy on ovarian function.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | radioactive iodine | 80-200 mCi of radioactive iodine will be given to thyroid cancer patients |
Timeline
- Start date
- 2020-06-15
- Primary completion
- 2021-06-15
- Completion
- 2021-12-15
- First posted
- 2020-05-20
- Last updated
- 2020-05-27
Source: ClinicalTrials.gov record NCT04396158. Inclusion in this directory is not an endorsement.